STEAP1 and neoplasm: Reassuringly, STEAP1-BBζ CAR T cell therapy at a dose sufficient to induce antitumor activity did not lead to evident systemic toxicities in hSTEAP1-KI mice including on-target off-tumor toxicities at sites of human STEAP1 expression.